Correlation Between Madrigal Pharmaceuticals and Roivant Sciences
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Roivant Sciences, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Roivant Sciences.
Diversification Opportunities for Madrigal Pharmaceuticals and Roivant Sciences
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Madrigal and Roivant is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Roivant Sciences go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Roivant Sciences
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.1 times less return on investment than Roivant Sciences. In addition to that, Madrigal Pharmaceuticals is 1.23 times more volatile than Roivant Sciences. It trades about 0.03 of its total potential returns per unit of risk. Roivant Sciences is currently generating about 0.04 per unit of volatility. If you would invest 942.00 in Roivant Sciences on August 31, 2024 and sell it today you would earn a total of 329.00 from holding Roivant Sciences or generate 34.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Roivant Sciences
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Roivant Sciences |
Madrigal Pharmaceuticals and Roivant Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Roivant Sciences
The main advantage of trading using opposite Madrigal Pharmaceuticals and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Roivant Sciences vs. Krystal Biotech | Roivant Sciences vs. Akero Therapeutics | Roivant Sciences vs. Apellis Pharmaceuticals | Roivant Sciences vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |